Treatment Information

Back

Liver Cancer treatment details. Chemotherapy, Immunotherapy.

Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Miami, Florida
Treatments:Chemotherapy, ImmunotherapyHospital:Sylvester Comprehensive Cancer Center, University of Miami
Drugs:Journal:Link
Date:Jan 2003

Description:

Patients: Thirty patients with unresectable hepatocellular (liver) carcinoma were entered into this Phase II trial.

Treatment: Treatment consisted of a combination of the chemotherapy drugs 5FUDR and doxorubicin (adriamycin) with recombinant leukocyte interferon.

Toxicity: Toxicities included: leucopenia (grade 3-4), thrombocytopenia (grade 3), fatigue (grade 3), anemia (grade 3), nausea, and vomiting.

Results: Median survival was 3 months.

Support: This study was supported in part by Roche Laboratories. Roche Laboratories markets Roferon (recombinant leukocyte interferon).




Back